EPN
EPSILON FPO [EPN]
Healthcare · ASX Small Cap
$0.0210 -4.6%
Updated 26 Mar 2026 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +15First seen: 2026-02-25
Score Breakdown
Technical54
Catalyst51
Sentiment50
Fundamental60
Momentum60
Risk Gate37
Get alerts when EPN's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- MACD momentum is losing steam
- Stochastic is deep in oversold territory — bounce conditions forming
- Sitting right at the lower Bollinger Band — oversold and potentially ready to snap back
- Sitting near support — this level has held before and could attract buyers again
- Drifting lower — down 8.7% over the last 5 days
- Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
- Critical cash runway (0.3 quarters)
- Low P/S ratio (0.9x)
- Strong revenue growth (+119%)
- Near 52-week low (0% of range)
- Micro-cap ($5-20M) - high risk
- New substantial holder(s) (1)
- Revenue growth 68% YoY (from results)
- Turned profitable (NPAT positive from results)
- Sentiment is mixed — no strong consensus either way
- Revenue growing at +119% — the top line is moving in the right direction
- Altman Z-Score distress zone (0.19 < 1.81, low-confidence approx)
- Low-priced stock risk ($0.021)
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Piotroski F-Score weak (2/9, low-confidence approx)
- Deeply negative margins (-22%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- The bigger volume days are the down days — volume-weighted momentum is negative (-1.05%/day)
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about EPN
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Preliminary Final Report
NONE Establishment of New Epsilon Biotech Subsidiary
NONE Application for quotation of securities - EPN
HIGH Becoming a substantial holder
Recent ASX Announcements
| 2026-02-27 | Preliminary Final Report PRICE SENSITIVE |
| 2026-02-17 | Establishment of New Epsilon Biotech Subsidiary |
| 2026-02-11 | Application for quotation of securities - EPN |
| 2026-02-06 | Becoming a substantial holder |
| 2026-02-05 | Application for quotation of securities - EPN |
Key Metrics
$8.2M
Market Cap
162K
Avg Volume
0.8x
Vol Ratio
$0.02 — $0.04
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-449.8%
ROE
-21.8%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 68% |
| L | Leader vs Laggard | laggard | RS: -10 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #18 of 117 · Sector avg: 46
View all Healthcare signals →Track EPN and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required